Stephen C Resch

Related Links

Biography

Stephen Resch, MPH, PhD, is a Lecturer on Health Decision Science in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. He is a core faculty member of the Center for Health Decision Science.

Dr. Resch's research focuses on advancing the use of decision analytic approaches in health policymaking and health program management. As a generalist with a passion for practical applications of technical analysis to aid decision-making, he often works closely with global health organizations and government officials across a broad range of public health topics and settings. Internationally, his work has addressed policy issues related to resource requirements, financial sustainability, and economic efficiency of health programs to treat or prevent of HIV, TB, malaria, and hepatitis, as well as programs to improve maternal and neonatal survival in childbirth, and vaccination. Domestically, he has worked on evaluation of obesity prevention interventions, HIV testing and linkage to care for incarcerated populations, and evaluation of dental interventions to prevent tooth decay in high-risk children.

Dr. Resch's work often involves constructing decision analytic models and employing computer simulation to predict health benefits, costs and other social impacts of alternative policy options. His core motivation is to aid decision makers in identifying decision criteria consistent with their goals and providing evidence that clarifies relevant constraints, trade-offs and uncertainties. He holds and MPH from Yale University and a PhD from Harvard University. He teaches a course on economic evaluation in the decision science curriculum at the Harvard Chan School.

Education and Training

• PhD, Health Policy
  Harvard University
• BS, Molecular Cell Biology
  University of Connecticut
• MPH, Health Policy
  Yale School of Public Health

Publications

• Cost- effectiveness of a simplified acute malnutrition program: a secondary analysis of the OptiMA randomized clinical trial in the Democratic Republic of the Congo.

  Resch SC, Sato R, Phelan K, Cazes C, Ombotimbe A, Hubert V, Boubacar H, Bozama LI, Sakubu GT, Tshiala BK, Tusuku T, Alitanou R, Kouamé A, Yao C, Gabillard D, Kinda M, Becquet R, Shepherd S, Hecht RM. Health Policy Plan 2024 Nov 08

• Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush.

  Clarke-Deelder E, Suharlim C, Chatterjee S, Portnoy A, Brenzel L, Ray A, Cohen JL, Menzies NA, Resch SC. Health Policy Plan 2024 Jun 03

• Preferences for Postacute Care at Home vs Facilities.

  Geng F, McGarry BE, Rosenthal MB, Zubizarreta JR, Resch SC, Grabowski DC. JAMA Health Forum 2024 Apr 05

• Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis-with an illustrative case of HIV treatment in Mozambique.

  Corlis J, Zhu J, Macul H, Tiberi O, Boothe MAS, Resch SC. Cost Eff Resour Alloc 2023 Sep 13

• Unit cost repositories for health program planning and evaluation: a report on research in practice with lessons learned.

  Bollinger LA, Corlis J, Ombam R, Forsythe S, Resch SC. BMC Public Health 2023 06 02